LRP5

Chr 11ADAR

LDL receptor related protein 5

Also known as: BMND1, EVR1, EVR4, HBM, LR3, LRP-5, LRP-7, LRP7

This gene encodes a transmembrane low-density lipoprotein receptor that binds and internalizes ligands in the process of receptor-mediated endocytosis. This protein also acts as a co-receptor with Frizzled protein family members for transducing signals by Wnt proteins and was originally cloned on the basis of its association with type 1 diabetes mellitus in humans. This protein plays a key role in skeletal homeostasis and many bone density related diseases are caused by mutations in this gene. Mutations in this gene also cause familial exudative vitreoretinopathy. Alternative splicing results in multiple transcript variants. [provided by RefSeq, May 2014]

Primary Disease Associations & Inheritance

[Bone mineral density variability 1, high bone mass]MIM #601884
AD
Endosteal hyperostosisMIM #144750
AD
Exudative vitreoretinopathy 4MIM #601813
ADAR
Osteopetrosis, autosomal dominant 1MIM #607634
AD
Osteoporosis-pseudoglioma syndromeMIM #259770
AR
Polycystic liver disease 4 with or without kidney cystsMIM #617875
AD
UniProtVitreoretinopathy, exudative 1
UniProtVitreoretinopathy, exudative 4
UniProtHigh bone mass trait
UniProtVan Buchem disease 2
500
ClinVar variants
59
Pathogenic / LP
0.51
pLI score
0
Active trials
Clinical SummaryLRP5
🧬
Gene-Disease Validity (ClinGen)
LRP5-related exudative vitreoretinopathy · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Moderately constrained gene (pLI 0.51) — some intolerance to loss-of-function variants.
📋
ClinVar Variants
59 Pathogenic / Likely Pathogenic· 291 VUS of 500 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

LoF intolerant — likely haploinsufficient
LoF Constraint?LOEUF (Loss-of-function Observed/Expected Upper bound Fraction) is the upper bound of the 90% CI for LoF OE — the preferred gnomAD v4 metric. Lower = more intolerant to LoF. LOEUF < 0.35 = highly constrained.
0.34LOEUF
pLI 0.510
Z-score 5.94
OE 0.22 (0.150.34)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?Missense Z-score: standard deviations fewer missense variants observed vs. expected. Z > 3.09 (p < 0.001) = gene does not tolerate missense variation. OE missense < 0.6 is also considered constrained.
1.67Z-score
OE missense 0.86 (0.810.91)
946 obs / 1101.8 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?Shaded band = 90% confidence interval. Vertical tick = point estimate. Grey threshold line = gnomAD constraint cutoff for that variant class.
LoF OE?Ratio of observed to expected LoF variants. Upper CI bound (LOEUF) ≤ 0.35 = strong LoF constraint signal.0.22 (0.150.34)
00.351.4
Missense OE?Ratio of observed to expected missense variants. OE ≤ 0.6 = fewer missense variants than expected by chance.0.86 (0.810.91)
00.61.4
Synonymous OE?Control metric — synonymous variants are largely neutral and expected near OE = 1.0. Significant deviation may indicate annotation issues.1.06
01.21.6
LoF obs/exp: 15 / 67.8Missense obs/exp: 946 / 1101.8Syn Z: -1.15

ClinVar Variant Classifications

500 submitted variants in ClinVar

Classification Summary

Pathogenic37
Likely Pathogenic22
VUS291
Likely Benign143
Benign1
Conflicting6
37
Pathogenic
22
Likely Pathogenic
291
VUS
143
Likely Benign
1
Benign
6
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
21
3
13
0
37
Likely Pathogenic
8
11
3
0
22
VUS
3
262
23
3
291
Likely Benign
0
2
57
84
143
Benign
0
0
1
0
1
Conflicting
6
Total322789787500

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

LRP5 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Gene2Phenotype Curations

LRP5-related osteopetrosis

definitive
ADGain Of FunctionAltered Gene Product Structure
Dev. DisordersSkeletal
G2P ↗
missense variantinframe deletioninframe insertion

LRP5-related osteoporosis-pseudoglioma syndrome on a spectrum with FEVR with osteopenia

definitive
ARLoss Of FunctionAbsent Gene Product
Dev. DisordersEyeSkeletal
G2P ↗

LRP5-related exudative vitreoretinopathy

definitive
ADLoss Of FunctionAbsent Gene Product
Dev. DisordersEye
G2P ↗

Gene2Phenotype curations · DECIPHER consortium patient cohort (public variants) · deciphergenomics.org

OMIM — Genotype-Phenotype Relationships

1 OMIM entry

[Bone mineral density variability 1, high bone mass]

MIM #601884

Molecular basis of disorder known

Autosomal dominant

Endosteal hyperostosis

MIM #144750

Molecular basis of disorder known

Autosomal dominant

Exudative vitreoretinopathy 4

MIM #601813

Molecular basis of disorder known

Autosomal dominantAutosomal recessive

Osteopetrosis, autosomal dominant 1

MIM #607634

Molecular basis of disorder known

Autosomal dominant

Osteoporosis-pseudoglioma syndrome

MIM #259770

Molecular basis of disorder known

Autosomal recessive

Polycystic liver disease 4 with or without kidney cysts

MIM #617875

Molecular basis of disorder known

Autosomal dominant
📖
GeneReview available — LRP5
Authoritative clinical overview · NCBI Bookshelf · Recommended first read
Open GeneReview ↗
Clinical Literature
Landmark / reviewRecent case evidence
Key Publications
Landmark & review papers · by relevance
PubMed
Early-Onset Osteoporosis.
Mäkitie O et al.·Calcif Tissue Int
2022Review
WNT signaling and cancer stemness.
Katoh M et al.·Essays Biochem
2022
Bone fragility and osteoporosis in children and young adults.
Formosa MM et al.·J Endocrinol Invest
2024Review
Sclerosing bone disorders.
de Vernejoul MC·Best Pract Res Clin Rheumatol
2008Review
Mendelian bone fragility disorders.
Robinson ME et al.·Bone
2019Review
Top 10 resultsSearch PubMed ↗

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →